135 related articles for article (PubMed ID: 20552702)
1. Identification of a uromodulin fragment for diagnosis of IgA nephropathy.
Wu J; Wang N; Wang J; Xie Y; Li Y; Liang T; Wang J; Yin Z; He K; Chen X
Rapid Commun Mass Spectrom; 2010 Jul; 24(14):1971-8. PubMed ID: 20552702
[TBL] [Abstract][Full Text] [Related]
2. Establishment of a 2-D human urinary proteomic map in IgA nephropathy.
Park MR; Wang EH; Jin DC; Cha JH; Lee KH; Yang CW; Kang CS; Choi YJ
Proteomics; 2006 Feb; 6(3):1066-76. PubMed ID: 16372274
[TBL] [Abstract][Full Text] [Related]
3. [Feasibility of peptide mass fingerprinting for differential diagnosis of IgA and non-IgA nephropathy].
Gao J; Wang Y; Wen XY; Lu HH; Dong ZN; Tian YP
Nan Fang Yi Ke Da Xue Xue Bao; 2011 Aug; 31(8):1309-13. PubMed ID: 21868311
[TBL] [Abstract][Full Text] [Related]
4. Mass spectrum analysis of serum biomarker proteins from patients with schizophrenia.
Zhou N; Wang J; Yu Y; Shi J; Li X; Xu B; Yu Q
Biomed Chromatogr; 2014 May; 28(5):654-9. PubMed ID: 24254984
[TBL] [Abstract][Full Text] [Related]
5. Proteomic analysis of urinary exosomes from patients of early IgA nephropathy and thin basement membrane nephropathy.
Moon PG; Lee JE; You S; Kim TK; Cho JH; Kim IS; Kwon TH; Kim CD; Park SH; Hwang D; Kim YL; Baek MC
Proteomics; 2011 Jun; 11(12):2459-75. PubMed ID: 21595033
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the specific structures of IgA1 hinge glycopeptide in 30 IgA nephropathy patients by mass spectrometry.
Odani H; Yamamoto K; Iwayama S; Iwase H; Takasaki A; Takahashi K; Fujita Y; Sugiyama S; Hiki Y
J Nephrol; 2010; 23(1):70-6. PubMed ID: 20091489
[TBL] [Abstract][Full Text] [Related]
7. Uromodulin and α(1)-antitrypsin urinary peptide analysis to differentiate glomerular kidney diseases.
Navarro-Muñoz M; Ibernon M; Bonet J; Pérez V; Pastor MC; Bayés B; Casado-Vela J; Navarro M; Ara J; Espinal A; Fluvià L; Serra A; López D; Romero R
Kidney Blood Press Res; 2012; 35(5):314-25. PubMed ID: 22399069
[TBL] [Abstract][Full Text] [Related]
8. A further investigation on a MALDI-based method for evaluation of markers of renal damage.
Lapolla A; Molin L; Sechi A; Cosma C; Ragazzi E; Seraglia R; Traldi P
J Mass Spectrom; 2009 Dec; 44(12):1754-60. PubMed ID: 19852035
[TBL] [Abstract][Full Text] [Related]
9. Serum under-galactosylated IgA1 is increased in Japanese patients with IgA nephropathy.
Shimozato S; Hiki Y; Odani H; Takahashi K; Yamamoto K; Sugiyama S
Nephrol Dial Transplant; 2008 Jun; 23(6):1931-9. PubMed ID: 18178603
[TBL] [Abstract][Full Text] [Related]
10. Electrophoretic methods for analysis of urinary polypeptides in IgA-associated renal diseases.
Julian BA; Wittke S; Novak J; Good DM; Coon JJ; Kellmann M; Zürbig P; Schiffer E; Haubitz M; Moldoveanu Z; Calcatera SM; Wyatt RJ; Sýkora J; Sládková E; Hes O; Mischak H; McGuire BM
Electrophoresis; 2007 Dec; 28(23):4469-83. PubMed ID: 18004714
[TBL] [Abstract][Full Text] [Related]
11. Rapid identification of protein biomarkers of Escherichia coli O157:H7 by matrix-assisted laser desorption ionization-time-of-flight-time-of-flight mass spectrometry and top-down proteomics.
Fagerquist CK; Garbus BR; Miller WG; Williams KE; Yee E; Bates AH; Boyle S; Harden LA; Cooley MB; Mandrell RE
Anal Chem; 2010 Apr; 82(7):2717-25. PubMed ID: 20232878
[TBL] [Abstract][Full Text] [Related]
12. IgA-containing immune complexes in the urine of IgA nephropathy patients.
Matousovic K; Novak J; Yanagihara T; Tomana M; Moldoveanu Z; Kulhavy R; Julian BA; Konecny K; Mestecky J
Nephrol Dial Transplant; 2006 Sep; 21(9):2478-84. PubMed ID: 16757497
[TBL] [Abstract][Full Text] [Related]
13. MALDI-TOF MS combined with magnetic beads for detecting serum protein biomarkers and establishment of boosting decision tree model for diagnosis of systemic lupus erythematosus.
Huang Z; Shi Y; Cai B; Wang L; Wu Y; Ying B; Qin L; Hu C; Li Y
Rheumatology (Oxford); 2009 Jun; 48(6):626-31. PubMed ID: 19389822
[TBL] [Abstract][Full Text] [Related]
14. The complex of immunoglobulin A and uromodulin as a diagnostic marker for immunoglobulin A nephropathy.
Obara T; Mizoguchi S; Shimozuru Y; Sato T; Hotta O
Clin Exp Nephrol; 2012 Oct; 16(5):713-21. PubMed ID: 22415778
[TBL] [Abstract][Full Text] [Related]
15. Urine protein profile of IgA nephropathy patients may predict the response to ACE-inhibitor therapy.
Rocchetti MT; Centra M; Papale M; Bortone G; Palermo C; Centonze D; Ranieri E; Di Paolo S; Gesualdo L
Proteomics; 2008 Jan; 8(1):206-16. PubMed ID: 18095357
[TBL] [Abstract][Full Text] [Related]
16. Poor histological lesions in IgA nephropathy may be reflected in blood and urine peptide profiling.
Graterol F; Navarro-Muñoz M; Ibernon M; López D; Troya MI; Pérez V; Bonet J; Romero R
BMC Nephrol; 2013 Apr; 14():82. PubMed ID: 23577616
[TBL] [Abstract][Full Text] [Related]
17. LG3 fragment of endorepellin is a possible biomarker of severity in IgA nephropathy.
Surin B; Sachon E; Rougier JP; Steverlynck C; Garreau C; Lelongt B; Ronco P; Piedagnel R
Proteomics; 2013 Jan; 13(1):142-52. PubMed ID: 23161552
[TBL] [Abstract][Full Text] [Related]
18. Promising diagnostic biomarkers for primary biliary cirrhosis identified with magnetic beads and MALDI-TOF-MS.
Li YZ; Hu CJ; Leng XM; Zhao GF; Li N; Xu Y
Anat Rec (Hoboken); 2009 Mar; 292(3):455-60. PubMed ID: 19248174
[TBL] [Abstract][Full Text] [Related]
19. A non-invasive diagnostic model of immunoglobulin A nephropathy and serological markers for evaluating disease severity.
Han QX; Wang Y; Zhu HY; Zhang D; Gao J; Liu ZS; Cai GY; Chen XM
Chin Med J (Engl); 2019 Mar; 132(6):647-652. PubMed ID: 30855344
[TBL] [Abstract][Full Text] [Related]
20. The potential biomarkers for thromboembolism detected by SELDI-TOF-MS.
Hong M; Zhang X; Hu Y; Wang H; He W; Mei H; Yu J; Guo T; Song S
Thromb Res; 2009; 123(3):556-64. PubMed ID: 18620739
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
